MedPath

Leuthromb

Brand Name: Leuthromb

Generic Name: Anagrelide

Active
Registration Number

DRP-16502

Dosage Form

Tablet

Issuance Date

March 31, 2025

Expiry Date

March 31, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mcg
PackagingAlu/PVDC Blister Pack x 10's (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent
A
Application
Initial (Re-application)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

AnagrelideActive
Monograph: Anagrelide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform